The 10 drugs that CMS might wrangle into negotiations

(By Paige Twenter for Becker’s Hospital Review)

CMS plans to soon release its list of 10 drugs that are up for price negotiations as it gears up to wield new powers granted by the Inflation Reduction Act, which passed in August 2022. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org